Tema Oncology ETF (CANC) Alternatives
Tema Oncology ETF (CANC) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with CANC. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.
Cheapest Alternatives to CANC
CANC charges 0.75% annually. Among ETFs in the Health & Biotech Equities category, these options have the lowest expense ratios among CANC alternatives.
| Symbol | Name | Expense Ratio | Inception | |
|---|---|---|---|---|
| Fidelity MSCI Health Care Index ETF | 0.08% | Oct 21, 2013 | CANC vs FHLC | |
| State Street Health Care Select Sector SPDR ETF | 0.08% | Dec 16, 1998 | CANC vs XLV | |
| Vanguard Health Care ETF | 0.10% | Jan 26, 2004 | CANC vs VHT | |
| Invesco S&P SmallCap Health Care ETF | 0.29% | Apr 7, 2010 | CANC vs PSCH | |
| SPDR S&P Pharmaceuticals ETF | 0.35% | Jun 19, 2006 | CANC vs XPH |
Best Risk-Adjusted Alternatives to CANC
Among ETFs in the Health & Biotech Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.
| Symbol | Name | Risk / Return Rank | Inception | |
|---|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | 97 | Dec 16, 2014 | CANC vs BBC | |
| ALPS Medical Breakthroughs ETF | 95 | Dec 31, 2014 | CANC vs SBIO | |
| SPDR S&P Biotech ETF | 92 | Feb 6, 2006 | CANC vs XBI | |
| F/m Emerald Life Sciences Innovation ETF | 86 | Oct 30, 2024 | CANC vs LFSC | |
| Invesco Nasdaq Biotechnology ETF | 86 | Jun 11, 2021 | CANC vs IBBQ |
Top Performing CANC Alternatives (YTD)
CANC alternatives from the Health & Biotech Equities category, sorted by year-to-date return.
| Symbol | Name | YTD Return | Inception | |
|---|---|---|---|---|
| iShares Genomics Immunology and Healthcare ETF Gen... | 10.92% | Jun 11, 2019 | CANC vs IDNA | |
| Virtus LifeSci Biotech Clinical Trials ETF | 7.95% | Dec 16, 2014 | CANC vs BBC | |
| SPDR S&P Biotech ETF | 4.76% | Feb 6, 2006 | CANC vs XBI | |
| First Trust Nasdaq Pharmaceuticals ETF | 4.48% | Sep 20, 2016 | CANC vs FTXH | |
| Virtus LifeSci Biotech Products ETF | 3.94% | Dec 17, 2014 | CANC vs BBP |
Lowest Volatility Alternatives to CANC
CANC alternatives from the Health & Biotech Equities category, sorted by annualized volatility over the past year.
| Symbol | Name | Volatility 1Y | Inception | |
|---|---|---|---|---|
| Principal Healthcare Innovators Index ETF | 0.00% | Aug 19, 2016 | CANC vs BTEC | |
| Loncar Cancer Immunotherapy ETF | 0.00% | Oct 13, 2015 | CANC vs CNCR | |
| Amplify Treatments, Testing and Advancements ETF | 0.00% | Jun 17, 2020 | CANC vs GERM | |
| Horizon Kinetics SPAC Active ETF | 8.60% | Jun 29, 2007 | CANC vs SPAQ | |
| Global X Aging Population ETF | 15.94% | May 9, 2016 | CANC vs AGNG |
Lowest Drawdown Alternatives to CANC
CANC alternatives from the Health & Biotech Equities category, sorted by maximum drawdown over the past year.
| Symbol | Name | Max Drawdown 1Y | Inception | |
|---|---|---|---|---|
| Amplify Treatments, Testing and Advancements ETF | 0.00% | Jun 17, 2020 | CANC vs GERM | |
| Horizon Kinetics SPAC Active ETF | -5.30% | Jun 29, 2007 | CANC vs SPAQ | |
| Jpmorgan Healthcare Leaders ETF | -9.68% | Nov 1, 2023 | CANC vs JDOC | |
| VanEck Vectors Pharmaceutical ETF | -10.02% | Dec 20, 2011 | CANC vs PPH | |
| Global X Aging Population ETF | -10.16% | May 9, 2016 | CANC vs AGNG |
Other ETFs from Tema
Most popular Tema ETFs on PortfoliosLab, across asset classes.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | Inception | |
|---|---|---|---|---|---|---|
| Tema American Reshoring ETF | Mid Cap Blend Equities | 89 | 12.27% | May 10, 2023 | CANC vs RSHO | |
| Tema Electrification ETF | Energy Equities | 97 | 18.37% | Dec 3, 2024 | CANC vs VOLT | |
| Tema Obesity & Cardiometabolic ETF | Health & Biotech Equities | 47 | -4.55% | Nov 20, 2023 | CANC vs HRTS | |
| Tema Monopolies and Oligopolies ETF | Large Cap Growth Equities | 22 | -4.23% | May 10, 2023 | CANC vs TOLL |
Often Compared With CANC
What investors most often compare with CANC, based on PortfoliosLab usage data.
Compare CANC with Any Fund or Stock
Compare CANC with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.